US Patent 7935723 Use of organic compounds
Patent 7935723 was granted and assigned to Novartis on May, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+235 characters)
Article
Patent abstract
A method for improving glucose control by administering metformin in combination with a DPP-IV inhibitor to a patient in need thereof, in an amount sufficient to control the glucose level over an extended period of time.
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07935723 Use of organic compounds US Patent 7935723 Use of organic compounds
Infobox
Patent Number
0793572300
Patent Number
793572300
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 26 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079357230
Date of Patent
May 3, 2011
0Patent Application Number
116285460
Date Filed
June 3, 2005
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079357230
Date of Patent
May 3, 2011
0Patent Application Number
116285460
Date Filed
June 3, 2005
0Official Website
Patent Primary Examiner
Edits on 19 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 7 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07935723 Use of organic compounds
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07935723
Date of patent
May 3, 2011
Patent application number
11628546
Date Filed
June 3, 2005
Patent primary examiner
Find more entities like US Patent 7935723 Use of organic compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
